Possibilities for refinement and reduction: Future improvements within regulatory testing

ILAR Journal

Volumn 43, Issue SUPPL., 2002, Pages

  Stephens, Martin L ^a   Conlee, Kathleen ^a   Alvino, Gina ^a   Rowan, Andrew N ^a  

^a NONE

Author keywords

Adverse effects; Analgesia; Anesthesia; Animal use alternatives; Carbon dioxide; Euthanasia; Methods; Research design; Statistics and numeral data

Indexed keywords

CARBON DIOXIDE; CHEMICAL AGENT;

ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL USE; ARTICLE; CANADA; CONTROLLED STUDY; EUTHANASIA; EXPERIMENTAL ANIMAL; EXPERIMENTAL DESIGN; IN VIVO STUDY; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; NON INVASIVE MEASUREMENT; NONHUMAN; PAIN ASSESSMENT; REVIEW; RODENT; SPECIES; TELEMETRY; UNITED STATES;

ANIMALIA; RODENTIA;

EID: 0036048275     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.43.suppl_1.s74     Document Type: Article

References (49)

1. 2000 Report of the AVMA Panel on Euthanasia
2. Refinement of euthanasia
3. 2 pulses applied to the nasal mucosa
4. Challenges in small animal noninvasive imaging
5. The three Rs: The way forward
6. CCAC Animal Use Survey
7. CCAC Guidelines on Choosing an Appropriate Endpoint in Experiments Using Animals for Research, Teaching and Testing
8. Use of positron emission tomography in animal research
9. Neglected Factors in Pharmacology and Neuroscience Research
10. Carbon dioxide euthanasia in rats: Oxygen supplementation minimizes signs of agitation and asphyxia
11. Humane endpoints in vaccine research and quality control
12. Humane practical implications of using carbon dioxide mixed with oxygen for anesthesia or euthanasia of rats
13. A good practice guide to the administration of substances and removal of blood, including routes and volumes
14. Working Party Report: Recommendations for euthanasia of experimental animals: Part 1
15. Respiratory artefact produced by carbon dioxide and pentobarbitone sodium euthanasia in rats
16. Reduction of animal use: Experimental design and quality of experiments
17. Reduction in animal use in the production and testing of biologicals
18. Reducing the use of laboratory animals in biomedical research: Problems and possible solutions
19. Refinement of animal use - Assessment and alleviation of pain and distress
20. Humane Endpoints in Animal Experiments for Biomedical Research
21. A comparison of euthanasia methods in rats, using carbon dioxide in prefilled and fixed flow rate filled chambers
22. Statistics of Scientific Procedures on Living Animals, Great Britain
23. Humane Endpoints for Animals Used in Biomedical Research and Testing
24. A murine local lymph node assay for the identification of contact allergens
25. The use of radiotelemetry in small laboratory animals: Recent advances
26. Prolonged antinociception following carbon dioxide anesthesia in the laboratory rat
27. Advances in refinement in animal experimentation over the past 25 years
28. The importance of non-statistical design in refining animal experimentation
29. A systematic approach for establishing humane endpoints
30. Refining procedures for the administration of substances
31. The effect of brief halothane anesthesia during daily gavage on complications and body weight in rats
32. Guidance Document on the Recognition, Assessment, and Use of Clinical Signs as Humane Endpoints for Experimental Animals Used in Safety Evaluation
33. ICH approaches to reducing animal use
34. A review of high-resolution x-ray computed tomography and other imaging modalities for small animal research
35. PHS Policy on Humane Care and Use of Laboratory Animals
36. Euthanasia of Animals Used for Scientific Purposes
37. Dosing limit volumes: The United Kingdom view-Past and present
38. The third R: Refinement
39. Animal welfare perspectives on pain and distress management in research and testing
40. The Principles of Humane Experimental Technique
41. Advancing refinement of laboratory animal use
42. 50) testing in the up and down procedure (UDP) in cytotoxicity data
43. The first forty years of the alternative approach: Refining, reducing, and replacing the use of laboratory animals
44. Unrelieved pain and distress in animals: An analysis of USDA data on experimental procedures
45. A major initiative from the European pharmaceutical industry and ECVAM